“…While children with gait impairments stand to benefit from RAGT, most commercially available exoskeletons are adult-oriented [8,9] and are not designed to serve the pediatric population [10]. Representative pediatric devices currently include the pediatric Lokomat [11], the Trexo robotic walker [12], the very small-sized Hybrid Assistive Limb (2S-HAL) [13], the ATLAS 2020 and 2030 [7,14], the MOTION exoskeleton by Bioengineering 2024, 11, 590 2 of 16 Zhang et al [15], and the exoskeletons developed by Lerner et al at the NIH [5]. Of the pediatric devices that do exist, few devices combine the characteristics of a lightweight form factor, community setting mobility, adjustability, and ease of use.…”